Identifying STEMI Patients for Early Intensive Care Unit Discharge: The Codi-IAM Score
Occhipinti, G.; Vilar-Roquet, D.; Guarinos Oltra, J.; Bermeo Garrido, J.; Carrillo Suarez, X.; Jimenez-Kockar, M.; Mila, L.; Andrea, R.; Cardenas Manilla, M.; Munoz Camacho, J.; Tomas-Querol, C.; Ribas-Barquet, N.; Mohandes, M.; Buera Surribas, I.; Garcia, C.; de Diego, O.; Llibre, C.; Ariza-Sole, A.; Freixa, X.; Barrabes, J. A.; Regueiro, A.; Rodes-Cabau, J.; Sabate, M.; Mauri, J.; Tizon-Marcos, H.; Abdul-Jawad Altisent, O.
Show abstract
BackgroundProlonged intensive care unit (ICU) monitoring after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) may be unnecessary for truly low-risk patients, yet no bedside tool reliably classify these patients. We aimed to develop and externally validate a score that identifies STEMI patients at very low risk of 30-day death or ICU-level complications after pPCI and to examine its prognostic value through two years. MethodsFrom July 2020 to July 2022, 5,093 consecutive STEMI patients treated with pPCI [≤]24 hours from symptom onset were prospectively enrolled across 10 centers in Catalonia Region. Derivation (n = 3,649) and validation (n = 1,444) cohorts were pre-specified. Multivariable logistic regression isolated independent predictors of the composite endpoint (30-day all-cause death or in-hospital complications requiring ICU care). Each predictor was weighted by its odds ratio to generate the Codi-IAM Score (0-24 points). ResultsSeven variables entered the score: age > 75 years, Killip > I, malignant peri-procedural arrhythmia, left-main disease, three-vessel disease, non-radial access, and unsuccessful PCI (final TIMI < 3). Discrimination was excellent (AUC 0.87 derivation; 0.86 validation). Very low-risk patients (score 0; 44.3% of the population) experienced no deaths within 72 hours, a 1.7% in-hospital complication rate, and 0.2% 30-day mortality; two-year survival exceeded 98%. ConclusionsThe Codi-IAM Score, available immediately after pPCI, accurately flags nearly half of STEMI patients as having negligible early risk. Its adoption could safely shorten ICU monitoring and hospital stay, improving resource allocation without impact on clinical outcomes. What Is KnownO_LIEarly intensive care unit (ICU) discharge after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) is recommended by current guidelines but remains limited by safety concerns. C_LIO_LICurrent European Society of Cardiology guidelines recommend at least 24 hours of continuous ICU monitoring for all STEMI patients, with only class IIb recommendation for early discharge within 72 hours. C_LIO_LIProlonged ICU stays may be associated with increased nosocomial complications, delayed mobilization, higher costs, and inefficient use of critical care resources, particularly relevant during healthcare system strain. C_LI What the Study AddsO_LIThe Codi-IAM Score is a simple, immediately available bedside tool incorporating seven variables that accurately identifies STEMI patients at very low risk of 30-day mortality or ICU-level complications after pPCI. C_LIO_LINearly half of STEMI patients (44.3%) score 0 on the Codi-IAM Score and experience negligible early risk: no deaths within 72 hours, 1.7% in-hospital complication rate, and 0.2% 30-day mortality. C_LIO_LIImplementation of the Codi-IAM Score in clinical practice could safely shorten ICU stays and hospital length of stay in approximately half of STEMI patients, improving resource allocation and patient satisfaction without compromising clinical outcomes over two-year follow-up. C_LI
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator 94%
- High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomised controlled trial 94%
- Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial 94%
Similar papers in this journal
- Prognostic Value of Patient-Reported Outcomes in Predicting Long-term Mortality after Transcatheter Aortic Valve Replacement (TAVR) 95%
- Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia. The Randomized RAIN-FLOW Study 95%
- Effectiveness of an Impella versus intra-aortic balloon pump in patients who received extracorporeal membrane oxygenation 94%
Similar papers in this journal
- Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions 95%
- Sex-Related Outcomes of Transcatheter Aortic Valve Implantation with Self-Expanding or Balloon-Expandable Valves: Insights from the OPERA-TAVI Registry 95%
- Ticagrelor vs Clopidogrel: the Impact of Platelet Inhibition on Cerebrovascular Microembolic Events during TAVR 95%
Similar papers in this journal
- Mortality Risk and Treatment Disparities in the Chinese SMuRF-less STEMI Patients: A Nationwide Cohort Study 95%
- Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease – a cohort study across sixteen countries 94%
- Right Ventricular Dysfunction: An Overlooked Predictor of Sudden Cardiac Death and Arrhythmic Events -- A Meta-Analysis 92%
Similar papers in this journal
- Natural History, Phenotype Spectrum and Clinical Outcomes of Desmin ( DES )-Associated Cardiomyopathy 92%
- Sex-Specific Clinical and Genetic Factors Associated with Adverse Outcomes in Hypertrophic Cardiomyopathy 92%
- Combining clinical and polygenic risk improves stroke prediction among individuals with atrial fibrillation 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.